Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

5 Apr 2022

Abstract excerpt

Antitumor activity of immune cells such as T cells and NK cells has made them auspicious therapeutic regimens for adaptive cancer immunotherapy. Enhancing their cytotoxic effects against malignancies and overcoming their suppression in tumor microenvironment (TME) may improve their efficacy to treat cancers. Clustered, regularly interspaced short palindromic repeats (CRISPR) genome editing has become one of the...

Source

Identifiers

PMID: 35449580
DOI: 10.3389/fonc.2022.834002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer ImmunotherapyPMID 35449580Read ↗

Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapySemantic proximity Read ↗

CRISPR, CAR-T, and NK: Current applications and future perspectivesSemantic proximity Read ↗

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapySemantic proximity Read ↗

CRISPR/Cas9 for cancer treatment: technology, clinical applications and challengesSemantic proximity Read ↗

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and ProblemsSemantic proximity Read ↗

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapySemantic proximity Read ↗

CRISPR/Cas9 edited tumor-associated immune cells in cancer immunotherapySemantic proximity Read ↗

CRISPR/Cas9 Gene-Editing in Cancer Immunotherapy: Promoting the Present Revolution in Cancer Therapy and Exploring MoreSemantic proximity Read ↗

CRISPR/Cas9-Mediated Genome Editing in Cancer TherapySemantic proximity Read ↗

CRISPR/Cas9: Role of genome editing in cancer immunotherapySemantic proximity Read ↗

CRISPR/Cas9-Mediated Customizing Strategies for Adoptive T-Cell TherapySemantic proximity Read ↗

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.